https://orcid.org/0000-0003-4416-6080
References
- Kidney Disease: Improving Global Outcomes. 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements; 2013. Available from: https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf. Accessed August 22, 2022.
- Guedes M, Robinson BM, Obrador G, Tong A, Pisoni RL, Pecoits-Filho R. Management of anemia in nondialysis chronic kidney disease: current recommendations, real-world practice, and patient perspectives. Kidney360. 2020;1(8):855–862. doi:10.34067/kid.0001442020
- Evans M, Bower H, Cockburn E, Jacobson SH, Barany P, Carrero JJ. Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis. Clin Kidney J. 2020;13(5):821–827. doi:10.1093/ckj/sfaa054
- Portolés J, Gorriz JL, Rubio E, et al. The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease. BMC Nephrol. 2013;14:2. doi:10.1186/1471-2369-14-2
- Palaka E, Grandy S, van Haalen H, McEwan P, Darlington O. The impact of CKD anaemia on patients: incidence, risk factors, and clinical outcomes – a systematic literature review. Int J Nephrol. 2020;2020:7692376. doi:10.1155/2020/7692376
- Alagoz S, Dincer MT, Eren N, et al. Prevalence of anemia in predialysis chronic kidney disease: is the study center a significant factor? PLoS One. 2020;15(4):e0230980. doi:10.1371/journal.pone.0230980
- Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney International Supplements; 2012. Available from: https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-Anemia-Guideline-English.pdf. Accessed August 22, 2022.
- Ogden L, Bennett L, Ebah LM. Iron deficiency anaemia in chronic kidney disease: an overview. J Kidney Care. 2018;3(Sup6):S3–S8. doi:10.12968/jokc.2018.3.Sup6.S3
- Wong MMY, Tu C, Li Y, et al. Anemia and iron deficiency among chronic kidney disease stages 3-5ND patients in the chronic kidney disease outcomes and practice patterns study: often unmeasured, variably treated. Clin Kidney J. 2019;13(4):613–624. doi:10.1093/ckj/sfz091
- Lopes MB, Tu C, Zee J, et al. A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: a multinational analysis of CKDopps. Sci Rep. 2021;11(1):1784. doi:10.1038/s41598-020-79254-6
- Minutolo R, Locatelli F, Gallieni M, et al. Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. Nephrol Dial Transplant. 2013;28(12):3035–3045. doi:10.1093/ndt/gft338
- UK Health Research Authority. Defining research table; 2017. Available from: http://www.hra-decisiontools.org.uk/research/docs/DefiningResearchTable_Oct2017-1.pdf. Accessed June 22, 2022.
- Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron deficiency anemia in chronic kidney disease. Acta Haematol. 2019;142(1):44–50. doi:10.1159/000496492
- Stack AG, Alghali A, Li X, et al. Quality of care and practice patterns in anaemia management at specialist kidney clinics in Ireland: a national study. Clin Kidney J. 2018;11(1):99–107. doi:10.1093/ckj/sfx060
- Rainey H. The challenges of managing iron deficiency anaemia in chronic kidney disease: survey results. J Kidney Care. 2018;3(Sup6):S9–S13. doi:10.12968/jokc.2018.3.sup6.s9
- Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A. Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management. Blood Purif. 2010;29(1):1–12. doi:10.1159/000245041